Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Gabrielsen

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Scandinavian Cardiovascular Journal : SCJ|July 11, 2008
YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery diseaseYongzhong Wang, Rasmus Sejersten Ripa, Julia Sidenius Johansen, et al.
Plos One|November 6, 2009
Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variantsLasse Folkersen, Theodosios Kyriakou, Anuj Goel, et al.
Clinical Drug Investigation|September 21, 2021
Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male SubjectsJane Knöchel, Karin Nelander, Maria Heijer, et al.
Neurobiology of Aging|May 12, 2024
Degree of multilingual engagement modulates resting state oscillatory activity across the lifespanToms Voits, Vincent DeLuca, Jiuzhou Hao, et al.
Plos One|August 1, 2012
Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart diseaseElena Nobili, M Dolores Salvado, Lasse Folkersen, et al.
Atherosclerosis|October 14, 2019
Endothelin-1 increases expression and activity of arginase 2 via ETB receptors and is co-expressed with arginase 2 in human atherosclerotic plaquesArnar Rafnsson, Ljubica Perisic Matic, Mariette Lengquist, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 19, 2002
Angiotensin II attenuates the natriuresis of water immersion in humansMorten Schou, Anders Gabrielsen, Niels Eske Bruun, et al.
Blood Advances|January 9, 2026
RNA interference therapy targeting coagulation factor XI - a first-in-human trial of RBD4059Anders Gabrielsen, Sebastian Ueckert, Catarina Nilsson, et al.
Atherosclerosis|April 20, 2006
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesionsPhan-Kiet Tran, Hanna E Agardh, Karin Tran-Lundmark, et al.
Clinical and Translational Science|August 16, 2022
Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trialIain B Squire, Anders Gabrielsen, Peter J Greasley, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Scandinavian Cardiovascular Journal : SCJ|July 11, 2008
YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery diseaseYongzhong Wang, Rasmus Sejersten Ripa, Julia Sidenius Johansen, et al.
Plos One|November 6, 2009
Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variantsLasse Folkersen, Theodosios Kyriakou, Anuj Goel, et al.
Clinical Drug Investigation|September 21, 2021
Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male SubjectsJane Knöchel, Karin Nelander, Maria Heijer, et al.
Neurobiology of Aging|May 12, 2024
Degree of multilingual engagement modulates resting state oscillatory activity across the lifespanToms Voits, Vincent DeLuca, Jiuzhou Hao, et al.
Plos One|August 1, 2012
Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart diseaseElena Nobili, M Dolores Salvado, Lasse Folkersen, et al.
Atherosclerosis|October 14, 2019
Endothelin-1 increases expression and activity of arginase 2 via ETB receptors and is co-expressed with arginase 2 in human atherosclerotic plaquesArnar Rafnsson, Ljubica Perisic Matic, Mariette Lengquist, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 19, 2002
Angiotensin II attenuates the natriuresis of water immersion in humansMorten Schou, Anders Gabrielsen, Niels Eske Bruun, et al.
Blood Advances|January 9, 2026
RNA interference therapy targeting coagulation factor XI - a first-in-human trial of RBD4059Anders Gabrielsen, Sebastian Ueckert, Catarina Nilsson, et al.
Atherosclerosis|April 20, 2006
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesionsPhan-Kiet Tran, Hanna E Agardh, Karin Tran-Lundmark, et al.
Clinical and Translational Science|August 16, 2022
Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trialIain B Squire, Anders Gabrielsen, Peter J Greasley, et al.
Pageof 6